RBR-3p7577已完成1 期
Comparison of Response to Vaccination with Three Different Schemes Pneumococcal Vaccine in Adults Infected by Human Immunodeficiency Virus
Hospital das Clínicas da Faculdade de Medicina da USP0 个研究点开始时间: 2013年3月13日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
入选标准
- •All individuals aged 18-60 years with HIV infection documented by enzyme-linked immunosorbent assay (ELISA) and Western-Blot testing, and with T-CD4 count above 200 cells/mm3 in two different occasions in the past six months were eligible. Were included in trial individuals who demonstrated understanding and signed consent form.
排除标准
- •Exclusion criteria included: any acute febrile illness at the moment of vaccination, active AIDS-defining clinical condition, previous immunization with any of the pneumococcal vaccines, any systemic malignancy neoplasm, use of immunoglobulin within the last three months, current pregnancy, antecedent of allergy to any of the pneumococcal vaccine components.
研究者
相似试验
已完成
4 期
Comparison of antibody response in children given 3 or 5 doses of an oral rotavirus vaccineCTRI/2012/02/002454Christian Medical College90
进行中（未招募）
不适用
Evaluation of the effectiveness of vaccination with 2009 H1N1 vaccines during influenza season 2010-112009 H1N1-influenssarokotteiden tehokkuus influenssakaudella 2010-11 - Pandemiarokotuskampanjan jatkotutkimusInfluenza caused by the 2009 H1N1 influenza virus (swine influenza)MedDRA version: 12.1Level: LLTClassification code 10022001Term: Influenza (epidemic)EUCTR2010-021033-30-FIational Institute for Health and Welfare3,000
尚未招募
不适用
To find out how many are affected with COVID after vaccination in a tertiary care hospitalCTRI/2021/07/034764SIMS SRM Institutes for Medical Science
进行中（未招募）
不适用
A study of the immune response to vaccination in MS patients treated with alemtuzumab - CAM-VACThe vaccinations are being used to investigate immunological memory following treatment of multiple sclerosis with the lympho-depleting humanised monoclonal antibody alemtuzumab.MedDRA version: 9.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisMedDRA version: 9.1Level: PTClassification code 10063400Term: Secondary progressive multiple sclerosisMedDRA version: 9.1Level: LLTClassification code 10046859Term: VaccinationEUCTR2009-011523-31-GBR & D, Cambridge University Hospitals60
进行中（未招募）
1 期
Immunological responses after concomitant vaccination with the yellow fever-vaccine and the TBE-vaccine, or JE-vaccinePrevention of TBE or Japanece encephalitis by co-vaccination with the yellow fever vaccineEUCTR2017-002137-32-SEHans-Gustaf Ljunggren140